Europe Self Injection Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
Europe self-injection market is expected to reach USD 17,595.22 million by 2024 from USD 7,133.88 million in 2016, at a CAGR of 11.9% in the forecast period 2017 to 2024.
Based on geography, the Europe self-injection market is segmented into 11 geographical regions, such as,
Sanofi is going to dominate the Europe self-injection market following with Novo Nordisk and Sandoz, Becton, Dickinson and Company along with others such as
The Europe self-injection market is segmented into 4 types, namely needle free injectors (NFI), auto injectors, pen injectors, and wearable injectors.
On the basis of applications, the Europe self-injection market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases, and others. In 2017, 48.7% market share for hormonal disorders applications segment is expected to dominate the market
On the basis of usage pattern the Europe self-injection market is segmented into curative care, immunization.
Based on mode of administration the market is segmented into circulatory, skin, organs and central nervous system.
On the basis of end user the Europe self-injection market is segmented into clinics, hospitals, home care settings, research laboratories and, pharma & biotech companies. In 2017 hospitals and clinics segment dominated the market and the trend is expected to remain the same till 2024.
Based on distribution channel, Europe self injection market is segmented into, Pharmacy stores, hospital pharmacy, direct tender and online pharmacy.
Based on geography, the Europe self-injection market is segmented into 11 geographical regions, such as,
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Turkey
- Belgium
- Netherlands
- Switzerland and
- Rest of Europe.
Sanofi is going to dominate the Europe self-injection market following with Novo Nordisk and Sandoz, Becton, Dickinson and Company along with others such as
- Mylan N.V.
- Gerresheimer AG
- West Pharmaceutical Services, Inc.
- Ypsomed
- Antares Pharma
- UNILIFE CORPORATION
The Europe self-injection market is segmented into 4 types, namely needle free injectors (NFI), auto injectors, pen injectors, and wearable injectors.
On the basis of applications, the Europe self-injection market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases, and others. In 2017, 48.7% market share for hormonal disorders applications segment is expected to dominate the market
On the basis of usage pattern the Europe self-injection market is segmented into curative care, immunization.
Based on mode of administration the market is segmented into circulatory, skin, organs and central nervous system.
On the basis of end user the Europe self-injection market is segmented into clinics, hospitals, home care settings, research laboratories and, pharma & biotech companies. In 2017 hospitals and clinics segment dominated the market and the trend is expected to remain the same till 2024.
Based on distribution channel, Europe self injection market is segmented into, Pharmacy stores, hospital pharmacy, direct tender and online pharmacy.
1. INTRODUCTION
1.1. OVERVIEW OF EUROPE SELF-INJECTION MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF CHRONIC DISEASES
3.1.2. RISING DEMAND OF SELF-INJECTION DEVICES
3.1.3. GROWTH OF BIOLOGICS MARKET
3.1.4. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN DRUG DELIVERY MARKET
3.2. RESTRAINTS
3.2.1. HIGH COST OF DEVELOPMENT
3.2.2. STRICT REGULATORY FRAMEWORK
3.3. OPPORTUNITY
3.3.1. INCREASING DEMAND FOR GENERIC AND BIOSIMILAR DRUGS
3.3.1.1. GENERICS
3.3.1.2. BIOSIMILARS
3.3.2. INCREASING DEMAND FOR CONTRACEPTIVE INJECTABLES
3.3.3. INCREASING DEMAND FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. ALTERNATIVE ROUTE OF DRUG ADMINISTRATION
3.4.2. PRODUCT RECALL
3.4.3. STABILITY OF PRODUCTS
3.4.4. STERILITY OF INJECTIONS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. EUROPE SELF-INJECTION MARKET, REGULATORY
6.1. OVERVIEW
6.2. U.S. FDA APPROVAL
6.3. CE MARKING (EUROPEAN CONFORMITY)
7. EUROPE SELF-INJECTION MARKET, REIMBUSEMENT
7.1. OVERVIEW
7.2. REIMBURSEMENT SCENARIO
8. EUROPE SELF-INJECTION MARKET, BY TYPE
8.1. OVERVIEW
8.2. EUROPE SELF-INJECTION MARKET, BY PRODUCT TYPE
8.2.1. NEEDLE FREE INJECTORS (NFI)
8.2.1.1. NEEDLE FREE INJECTORS, BY PRODUCT
8.2.1.2. NEEDLE FREE INJECTORS, BY TECHNOLOGY
LASER BASED NEEDLE FREE INJECTORS:
VIBRATION BASED NEEDLE FREE INJECTORS:
8.2.1.3. NEEDLE FREE INJECTORS, BY USABILITY
REUSABLE NEEDLE-FREE INJECTORS
DISPOSABLE NEEDLE-FREE INJECTORS
8.2.2. AUTO INJECTORS
8.2.2.1. AUTO INJECTORS, BY PRODUCT
FILLABLE AUTO INJECTORS
PRE-FILLED AUTO INJECTORS
8.2.2.2. AUTO INJECTORS, BY TECHNOLOGY
AUTOMATED AUTO INJECTORS
MANUAL AUTO INJECTORS
8.2.2.3. AUTO INJECTORS, BY DESIGN
STANDARDIZED AUTO INJECTORS
CUSTOMIZEDAUTO INJECTORS
8.2.2.4. AUTO INJECTORS, BY USABILITY
REUSABLE AUTO INJECTORS
DISPOSABLE AUTO INJECTORS
8.2.3. PEN INJECTORS
8.2.3.1. PEN INJECTORS, BY PRODUCT
SINGLE CHAMBERED PEN INJECTORS
DUAL CHAMBERED PEN INJECTORS
8.2.3.2. PEN INJECTORS, BY DESIGN
STANDARD PEN INJECTORS
CUSTOMIZED PEN INJECTORS
8.2.3.3. PEN INJECTORS, BY USABILITY
REUSABLE PEN INJECTORS
DISPOSABLE PEN INJECTORS
8.2.4. WEARABLE INJECTORS
9. EUROPE SELF-INJECTION MARKET, BY APPLICATION
9.1. OVERVIEW
9.2. EUROPE SELF-INJECTION MARKET, BY APPLICATION
9.3. HORMONAL DISORDERS
9.3.1. SELF-INJECTIONS FOR DIABETES
9.3.2. SELF-INJECTIONSFOR ANEMIA
9.3.3. REPRODUCTIVE HEALTH DISEASE
9.3.4. OSTEOPOROSIS
9.3.5. GROWTH HORMONE DISORDERS (GHD)
9.4. ONCOLOGY
9.5. AUTOIMMUNE DISEASES
9.5.1. RHEUMATOID ARTHRITIS
9.5.2. MULTIPLE SCLEROSIS
9.5.3. CROHN’S DISEASES
9.5.4. PSORIASIS
9.5.5. OTHER AUTOIMMUNE DISEASES
9.6. ORPHAN DISEASE
9.7. OTHER APPLICATIONS
9.7.1. PAIN MANAGEMENT
9.7.2. ALLERGY TREATMENT
9.7.3. AESTHETIC TREATMENTS
9.7.4. HEPATITIS C
9.7.5. HEMOPHILIA
10. EUROPE SELF-INJECTION MARKET, BY USAGE PATTERN
10.1. OVERVIEW
10.2. CURATIVE CARE
10.3. IMMUNIZATIONS
10.4. OTHER USAGE PATTERN
11. EUROPE SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION
11.1. OVERVIEW
11.2. SKIN
11.3. CIRCULATORY/ MUSKOSKELETAL
11.4. ORGANS
11.5. CENTRAL NERVOUS SYSTEM
12. EUROPE SELF-INJECTION MARKET, BY END USER
12.1. OVERVIEW
12.2. HOSPITALS AND CLINICS
12.3. HOME HEALTHCARE SETTINGS
12.4. RESEARCH LABORATORIES
12.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
12.6. OTHER END USER
13. EUROPE SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL
13.1. OVERVIEW
13.1.1. HOSPITAL PHARMACY
13.1.2. PHARMACY STORES
13.1.3. DIRECT TENDER
13.1.4. ONLINE PHARMACY
14. EUROPE SELF-INJECTION MARKET, BY GEOGRAPHY
14.1. OVERVIEW
14.2. EUROPE
14.2.1. GERMANY
14.2.2. FRANCE
14.2.3. UK
14.2.4. SWITZERLAND
14.2.5. SPAIN
14.2.6. ITALY
14.2.7. NETHERLANDS
14.2.8. RUSSIA
14.2.9. TURKEY
14.2.10. BELGIUM
14.2.11. REST OF EUROPE
15. EUROPE SELF INJECTION MARKET, COMPANY LANDSCAPE
15.1. COMPANY SHARE ANALYSIS: EUROPE
15.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3. COMPANY SHARE ANALYSIS: EUROPE
15.4. COMPANY SHARE ANALYSIS: APAC
16. COMPANY PROFILES
16.1. ELCAM MEDICALCOMPANY OVERVIEW
16.1.1. ELCAM MEDICAL: COMPANY SNAPSHOT
16.1.2. PRODUCT PORTFOLIO
16.1.3. RECENT DEVELOPMENTS
16.2. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)
16.2.1. COMPANY OVERVIEW
16.2.2. BESPAK: REVENUE ANALYSIS
16.2.3. PRODUCT PORTFOLIO
16.2.4. RECENT DEVELOPMENTS
16.3. SANOFI
16.3.1. COMPANY OVERVIEW
16.3.2. SANOFI: REVENUE ANALYSI
16.3.3. PRODUCT PORTFOLIO
16.3.4. RECENT DEVELOPMENTS
16.4. SANDOZ INTERNATIONAL GMBH
16.4.1. COMPANY OVERVIEW
16.5. SANDOZ INTERNATIONAL GMBH: REVENUE ANALYSIS
16.5.1. PRODUCT PORTFOLIO
16.5.2. RECENT DEVELOPMENTS
16.6. UNILIFE CORPORATION
16.6.1. COMPANY OVERVIEW
16.6.2. UNILIFE CORPORATION: REVENUEANALYSIS
16.6.3. PRODUCT PORTFOLIO
16.6.4. RECENT DEVELOPMENTS
16.7. WEST PHARMACEUTICAL SERVICES, INC
16.7.1. COMPANY OVERVIEW
16.7.2. WEST PHARMACEUTICAL SERVICES, INC: REVENUE ANALYSIS
16.7.3. PRODUCT PORTFOLIO
16.7.4. RECENT DEVELOPMENTS
16.8. PFIZER INC.
16.8.1. COMPANY OVERVIEW
16.8.2. PFIZER INC: REVENUE ANALYSIS
16.8.3. PRODUCT PORTFOLIO
16.8.4. RECENT DEVELOPMENTS
16.9. IMPAX LABORATORIES, INC.
16.9.1. COMPANY OVERVIEW
16.9.2. IMPAX LABORATORIES, INC: REVENUE ANALYSIS
16.9.3. PRODUCT PORTFOLIO
16.9.4. RECENT DEVELOPMENTS
16.10. PENJET CORPORATION
16.10.1. COMPANY OVERVIEW
16.10.2. PENJET CORPORATION: COMPANY SNAPSHOT
16.10.3. PRODUCT PORTFOLIO
16.10.4. RECENT DEVELOPMENTS
16.11. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS
16.11.1. COMPANY OVERVIEW
16.11.2. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS: COMPANY SNAPSHOT
16.11.3. PRODUCT PORTFOLIO
16.11.4. RECENT DEVELOPMENTS
16.12. WILHELM HASELMEIER GMBH & CO. KG
16.12.1. COMPANY OVERVIEW
16.12.2. HASELMEIER: COMPANY SNAPSHOT
16.12.3. PRODUCT PORTFOLIO
16.12.4. RECENT DEVELOPMENTS
16.13. ANTARES PHARMA
16.13.1. COMPANY OVERVIEW
16.13.2. ANTARES PHARMA: REVENUE ANALYSIS
16.13.3. PRODUCT PORTFOLIO
16.13.4. RECENT DEVELOPMENTS
16.14. BECTON, DICKINSON AND COMPANY
16.14.1. COMPANY OVERVIEW
16.14.2. BECTON, DICKINSON AND COMPANY: REVENUE ANALYSIS
16.14.3. PRODUCT PORTFOLIO
16.14.4. RECENT DEVELOPMENTS
16.15. GERRESHEIMER AG
16.15.1. COMPANY OVERVIEW
16.15.2. GERRESHEIMER AG: REVENUE ANALYSIS
16.15.3. PRODUCT PORTFOLIO
16.15.4. RECENT DEVELOPMENTS
16.16. MYLAN N.V
16.16.1. COMPANY OVERVIEW
16.16.2. MYLAN N.V.: REVENUE ANALYSIS
16.16.3. PRODUCT PORTFOLIO
16.16.4. RECENT DEVELOPMENTS
16.17. NOVO NORDISK
16.17.1. COMPANY OVERVIEW
16.17.2. NOVO NORDISK: REVENUE ANALYSIS
16.17.3. PRODUCT PORTFOLIO
16.17.4. RECENT DEVELOPMENTS
16.18. OWEN MUMFORD LTD
16.18.1. COMPANY OVERVIEW
16.18.2. OWEN MUMFORD LTD: COMPANY SNAPSHOT
16.18.3. PRODUCT PORTFOLIO
16.18.4. RECENT DEVELOPMENTS
16.19. PHARMAJET
16.19.1. COMPANY OVERVIEW
16.19.2. PHARMAJET: COMPANY SNAPSHOT
16.19.3. PRODUCT PORTFOLIO
16.19.4. RECENT DEVELOPMENTS
16.20. SHL GROUP
16.20.1. COMPANY OVERVIEW
16.20.2. SHL GROUP: COMPANY SNAPSHOT
16.20.3. PRODUCT PORTFOLIO
16.20.4. RECENT DEVELOPMENTS
16.21. YPSOMED
16.21.1. COMPANY OVERVIEW
16.21.2. YPSOMED: REVENUE ANALYSIS
16.21.3. PRODUCT PORTFOLIO
16.21.4. RECENT DEVELOPMENTS
17. RELATED REPORTS
1.1. OVERVIEW OF EUROPE SELF-INJECTION MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF CHRONIC DISEASES
3.1.2. RISING DEMAND OF SELF-INJECTION DEVICES
3.1.3. GROWTH OF BIOLOGICS MARKET
3.1.4. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN DRUG DELIVERY MARKET
3.2. RESTRAINTS
3.2.1. HIGH COST OF DEVELOPMENT
3.2.2. STRICT REGULATORY FRAMEWORK
3.3. OPPORTUNITY
3.3.1. INCREASING DEMAND FOR GENERIC AND BIOSIMILAR DRUGS
3.3.1.1. GENERICS
3.3.1.2. BIOSIMILARS
3.3.2. INCREASING DEMAND FOR CONTRACEPTIVE INJECTABLES
3.3.3. INCREASING DEMAND FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. ALTERNATIVE ROUTE OF DRUG ADMINISTRATION
3.4.2. PRODUCT RECALL
3.4.3. STABILITY OF PRODUCTS
3.4.4. STERILITY OF INJECTIONS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. EUROPE SELF-INJECTION MARKET, REGULATORY
6.1. OVERVIEW
6.2. U.S. FDA APPROVAL
6.3. CE MARKING (EUROPEAN CONFORMITY)
7. EUROPE SELF-INJECTION MARKET, REIMBUSEMENT
7.1. OVERVIEW
7.2. REIMBURSEMENT SCENARIO
8. EUROPE SELF-INJECTION MARKET, BY TYPE
8.1. OVERVIEW
8.2. EUROPE SELF-INJECTION MARKET, BY PRODUCT TYPE
8.2.1. NEEDLE FREE INJECTORS (NFI)
8.2.1.1. NEEDLE FREE INJECTORS, BY PRODUCT
8.2.1.2. NEEDLE FREE INJECTORS, BY TECHNOLOGY
LASER BASED NEEDLE FREE INJECTORS:
VIBRATION BASED NEEDLE FREE INJECTORS:
8.2.1.3. NEEDLE FREE INJECTORS, BY USABILITY
REUSABLE NEEDLE-FREE INJECTORS
DISPOSABLE NEEDLE-FREE INJECTORS
8.2.2. AUTO INJECTORS
8.2.2.1. AUTO INJECTORS, BY PRODUCT
FILLABLE AUTO INJECTORS
PRE-FILLED AUTO INJECTORS
8.2.2.2. AUTO INJECTORS, BY TECHNOLOGY
AUTOMATED AUTO INJECTORS
MANUAL AUTO INJECTORS
8.2.2.3. AUTO INJECTORS, BY DESIGN
STANDARDIZED AUTO INJECTORS
CUSTOMIZEDAUTO INJECTORS
8.2.2.4. AUTO INJECTORS, BY USABILITY
REUSABLE AUTO INJECTORS
DISPOSABLE AUTO INJECTORS
8.2.3. PEN INJECTORS
8.2.3.1. PEN INJECTORS, BY PRODUCT
SINGLE CHAMBERED PEN INJECTORS
DUAL CHAMBERED PEN INJECTORS
8.2.3.2. PEN INJECTORS, BY DESIGN
STANDARD PEN INJECTORS
CUSTOMIZED PEN INJECTORS
8.2.3.3. PEN INJECTORS, BY USABILITY
REUSABLE PEN INJECTORS
DISPOSABLE PEN INJECTORS
8.2.4. WEARABLE INJECTORS
9. EUROPE SELF-INJECTION MARKET, BY APPLICATION
9.1. OVERVIEW
9.2. EUROPE SELF-INJECTION MARKET, BY APPLICATION
9.3. HORMONAL DISORDERS
9.3.1. SELF-INJECTIONS FOR DIABETES
9.3.2. SELF-INJECTIONSFOR ANEMIA
9.3.3. REPRODUCTIVE HEALTH DISEASE
9.3.4. OSTEOPOROSIS
9.3.5. GROWTH HORMONE DISORDERS (GHD)
9.4. ONCOLOGY
9.5. AUTOIMMUNE DISEASES
9.5.1. RHEUMATOID ARTHRITIS
9.5.2. MULTIPLE SCLEROSIS
9.5.3. CROHN’S DISEASES
9.5.4. PSORIASIS
9.5.5. OTHER AUTOIMMUNE DISEASES
9.6. ORPHAN DISEASE
9.7. OTHER APPLICATIONS
9.7.1. PAIN MANAGEMENT
9.7.2. ALLERGY TREATMENT
9.7.3. AESTHETIC TREATMENTS
9.7.4. HEPATITIS C
9.7.5. HEMOPHILIA
10. EUROPE SELF-INJECTION MARKET, BY USAGE PATTERN
10.1. OVERVIEW
10.2. CURATIVE CARE
10.3. IMMUNIZATIONS
10.4. OTHER USAGE PATTERN
11. EUROPE SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION
11.1. OVERVIEW
11.2. SKIN
11.3. CIRCULATORY/ MUSKOSKELETAL
11.4. ORGANS
11.5. CENTRAL NERVOUS SYSTEM
12. EUROPE SELF-INJECTION MARKET, BY END USER
12.1. OVERVIEW
12.2. HOSPITALS AND CLINICS
12.3. HOME HEALTHCARE SETTINGS
12.4. RESEARCH LABORATORIES
12.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
12.6. OTHER END USER
13. EUROPE SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL
13.1. OVERVIEW
13.1.1. HOSPITAL PHARMACY
13.1.2. PHARMACY STORES
13.1.3. DIRECT TENDER
13.1.4. ONLINE PHARMACY
14. EUROPE SELF-INJECTION MARKET, BY GEOGRAPHY
14.1. OVERVIEW
14.2. EUROPE
14.2.1. GERMANY
14.2.2. FRANCE
14.2.3. UK
14.2.4. SWITZERLAND
14.2.5. SPAIN
14.2.6. ITALY
14.2.7. NETHERLANDS
14.2.8. RUSSIA
14.2.9. TURKEY
14.2.10. BELGIUM
14.2.11. REST OF EUROPE
15. EUROPE SELF INJECTION MARKET, COMPANY LANDSCAPE
15.1. COMPANY SHARE ANALYSIS: EUROPE
15.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3. COMPANY SHARE ANALYSIS: EUROPE
15.4. COMPANY SHARE ANALYSIS: APAC
16. COMPANY PROFILES
16.1. ELCAM MEDICALCOMPANY OVERVIEW
16.1.1. ELCAM MEDICAL: COMPANY SNAPSHOT
16.1.2. PRODUCT PORTFOLIO
16.1.3. RECENT DEVELOPMENTS
16.2. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)
16.2.1. COMPANY OVERVIEW
16.2.2. BESPAK: REVENUE ANALYSIS
16.2.3. PRODUCT PORTFOLIO
16.2.4. RECENT DEVELOPMENTS
16.3. SANOFI
16.3.1. COMPANY OVERVIEW
16.3.2. SANOFI: REVENUE ANALYSI
16.3.3. PRODUCT PORTFOLIO
16.3.4. RECENT DEVELOPMENTS
16.4. SANDOZ INTERNATIONAL GMBH
16.4.1. COMPANY OVERVIEW
16.5. SANDOZ INTERNATIONAL GMBH: REVENUE ANALYSIS
16.5.1. PRODUCT PORTFOLIO
16.5.2. RECENT DEVELOPMENTS
16.6. UNILIFE CORPORATION
16.6.1. COMPANY OVERVIEW
16.6.2. UNILIFE CORPORATION: REVENUEANALYSIS
16.6.3. PRODUCT PORTFOLIO
16.6.4. RECENT DEVELOPMENTS
16.7. WEST PHARMACEUTICAL SERVICES, INC
16.7.1. COMPANY OVERVIEW
16.7.2. WEST PHARMACEUTICAL SERVICES, INC: REVENUE ANALYSIS
16.7.3. PRODUCT PORTFOLIO
16.7.4. RECENT DEVELOPMENTS
16.8. PFIZER INC.
16.8.1. COMPANY OVERVIEW
16.8.2. PFIZER INC: REVENUE ANALYSIS
16.8.3. PRODUCT PORTFOLIO
16.8.4. RECENT DEVELOPMENTS
16.9. IMPAX LABORATORIES, INC.
16.9.1. COMPANY OVERVIEW
16.9.2. IMPAX LABORATORIES, INC: REVENUE ANALYSIS
16.9.3. PRODUCT PORTFOLIO
16.9.4. RECENT DEVELOPMENTS
16.10. PENJET CORPORATION
16.10.1. COMPANY OVERVIEW
16.10.2. PENJET CORPORATION: COMPANY SNAPSHOT
16.10.3. PRODUCT PORTFOLIO
16.10.4. RECENT DEVELOPMENTS
16.11. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS
16.11.1. COMPANY OVERVIEW
16.11.2. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS: COMPANY SNAPSHOT
16.11.3. PRODUCT PORTFOLIO
16.11.4. RECENT DEVELOPMENTS
16.12. WILHELM HASELMEIER GMBH & CO. KG
16.12.1. COMPANY OVERVIEW
16.12.2. HASELMEIER: COMPANY SNAPSHOT
16.12.3. PRODUCT PORTFOLIO
16.12.4. RECENT DEVELOPMENTS
16.13. ANTARES PHARMA
16.13.1. COMPANY OVERVIEW
16.13.2. ANTARES PHARMA: REVENUE ANALYSIS
16.13.3. PRODUCT PORTFOLIO
16.13.4. RECENT DEVELOPMENTS
16.14. BECTON, DICKINSON AND COMPANY
16.14.1. COMPANY OVERVIEW
16.14.2. BECTON, DICKINSON AND COMPANY: REVENUE ANALYSIS
16.14.3. PRODUCT PORTFOLIO
16.14.4. RECENT DEVELOPMENTS
16.15. GERRESHEIMER AG
16.15.1. COMPANY OVERVIEW
16.15.2. GERRESHEIMER AG: REVENUE ANALYSIS
16.15.3. PRODUCT PORTFOLIO
16.15.4. RECENT DEVELOPMENTS
16.16. MYLAN N.V
16.16.1. COMPANY OVERVIEW
16.16.2. MYLAN N.V.: REVENUE ANALYSIS
16.16.3. PRODUCT PORTFOLIO
16.16.4. RECENT DEVELOPMENTS
16.17. NOVO NORDISK
16.17.1. COMPANY OVERVIEW
16.17.2. NOVO NORDISK: REVENUE ANALYSIS
16.17.3. PRODUCT PORTFOLIO
16.17.4. RECENT DEVELOPMENTS
16.18. OWEN MUMFORD LTD
16.18.1. COMPANY OVERVIEW
16.18.2. OWEN MUMFORD LTD: COMPANY SNAPSHOT
16.18.3. PRODUCT PORTFOLIO
16.18.4. RECENT DEVELOPMENTS
16.19. PHARMAJET
16.19.1. COMPANY OVERVIEW
16.19.2. PHARMAJET: COMPANY SNAPSHOT
16.19.3. PRODUCT PORTFOLIO
16.19.4. RECENT DEVELOPMENTS
16.20. SHL GROUP
16.20.1. COMPANY OVERVIEW
16.20.2. SHL GROUP: COMPANY SNAPSHOT
16.20.3. PRODUCT PORTFOLIO
16.20.4. RECENT DEVELOPMENTS
16.21. YPSOMED
16.21.1. COMPANY OVERVIEW
16.21.2. YPSOMED: REVENUE ANALYSIS
16.21.3. PRODUCT PORTFOLIO
16.21.4. RECENT DEVELOPMENTS
17. RELATED REPORTS
LIST OF TABLES
TABLE 1 EUROPE SELF-INJECTION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
TABLE 2 EUROPE SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 3 EUROPE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 4 EUROPE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 5 EUROPE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY,2015 – 2024 (USD MILLION)
TABLE 6 EUROPE AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 7 EUROPE AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 8 EUROPE AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 9 EUROPE AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 10 EUROPE PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 11 EUROPE PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 12 EUROPE PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 13 EUROPE SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 14 EUROPE AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 15 EUROPE HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 16 EUROPE OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 17 EUROPE SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 18 EUROPE SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 19 EUROPE SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 20 EUROPE SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 21 GERMANY SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 22 GERMANY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT,2015 – 2024 (USD MILLION)
TABLE 23 GERMANY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 24 GERMANY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 25 GERMANY AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 26 GERMANY AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 27 GERMANY AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 28 GERMANY AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 29 GERMANY PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 30 GERMANY PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 31 GERMANY PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 32 GERMANY SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 33 GERMANY AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 34 GERMANY HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 35 GERMANY OTHERS SELF-INJECTION MARKET, BYAPPLICATION, 2015 – 2024 (USD MILLION)
TABLE 36 GERMANY SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 37 GERMANY SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 38 GERMANY SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 39 GERMANY SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 40 FRANCE SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 41 FRANCE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 42 FRANCE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 43 FRANCE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 44 FRANCE AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 45 FRANCE A;UTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 46 FRANCE AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 47 FRANCE AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 48 FRANCE PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 49 FRANCE PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 50 FRANCE PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 51 FRANCE SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 52 FRANCE AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 53 FRANCE HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 54 FRANCE OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 55 FRANCE SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 56 FRANCE SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 57 FRANCE SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 58 FRANCE SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 59 UK SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 60 UK NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 61 UK NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 62 UK NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 63 UK AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 64 UK AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 65 UK AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 66 UK AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 67 UK PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 68 UK PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 69 UK PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 70 UK SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 71 UK AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 72 UK HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 73 UK OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 74 UK SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 75 UK SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 76 UK SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 77 UK SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 78 SWITZERLAND SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 79 SWITZERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 80 SWITZERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 81 SWITZERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY,2015 – 2024 (USD MILLION)
TABLE 82 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 83 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 84 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 85 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 86 SWITZERLAND PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 87 SWITZERLAND PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 88 SWITZERLAND PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 89 SWITZERLAND SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 90 SWITZERLAND AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 91 SWITZERLAND HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 92 SWITZERLAND OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 93 SWITZERLAND SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 94 SWITZERLAND SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 95 SWITZERLAND SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 96 SWITZERLAND SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL
2015– 2024 (USD MILLION)
TABLE 97 SPAIN SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 98 SPAIN NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 99 SPAIN NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 100 SPAIN NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 101 SPAIN AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 102 SPAIN AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 103 SPAIN AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 104 SPAIN AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 105 SPAIN PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 106 SPAIN PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 107 SPAIN PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 108 SPAIN SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 109 SPAIN AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 110 SPAIN HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 111 SPAIN OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 112 SPAIN SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 113 SPAIN SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 114 SPAIN SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 115 SPAIN SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 116 ITALY SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 117 ITALY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 118 ITALY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 119 ITALY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 120 ITALY AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 121 ITALY AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 122 ITALY AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 123 ITALY AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 124 ITALY PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 125 ITALY PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 126 ITALY PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 127 ITALY SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 128 ITALY AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 129 ITALY HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 130 ITALY OTHER SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 131 ITALY SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 132 ITALY SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 133 ITALY SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 134 ITALY SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 135 NETHERLANDS SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 136 NETHERLANDS NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 137 NETHERLANDS NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 138 NETHERLANDS NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 139 NETHERLANDS AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 140 NETHERLANDS AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 141 NETHERLANDS AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 142 NETHERLANDS AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 143 NETHERLANDS PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 144 NETHERLANDS PEN INJECTORS DEVICE MARKET, BY DESIGN 2015 – 2024 (USD MILLION)
TABLE 145 NETHERLANDS PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 146 NETHERLANDSSELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 147 NETHERLANDS AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 148 NETHERLANDS HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 149 NETHERLANDS OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 150 NETHERLANDSSELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 151 NETHERLANDSSELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 152 NETHERLANDSSELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 153 NETHERLANDS SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 154 RUSSIA SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 155 RUSSIA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 156 RUSSIA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 157 RUSSIA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 158 RUSSIA AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 158 RUSSIA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 159 RUSSIA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 160 RUSSIA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 161 RUSSIA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 162 RUSSIA PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 163 RUSSIA PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 164 RUSSIA SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 165 RUSSIA AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 166 RUSSIA HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 167 RUSSIA OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 168 RUSSIA SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 169 RUSSIA SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 170 RUSSIA SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 171 RUSSIA SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION
TABLE 172 TURKEY SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 173 TURKEY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 174 TURKEY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 175 TURKEY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 176 TURKEY AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 177 TURKEY AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 178 TURKEY AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 179 TURKEY AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 180 TURKEY PEN INJECTORS DEVICE MARKET, BY PRODUCT 2015 – 2024 (USD MILLION)
TABLE 181 TURKEY PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 182 TURKEY PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 183 TURKEY SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 184 TURKEY AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 185 TURKEY HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 186 TURKEY OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 187 TURKEY SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 188 TURKEY SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 189 TURKEY SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 190 TURKEY SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 191 BELGIUM SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 192 BELGIUM NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 193 BELGIUM NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 194 BELGIUM NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 195 BELGIUM AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 196 BELGIUM AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 197 BELGIUM AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 198 BELGIUM AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 199 BELGIUM PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 200 BELGIUM PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 201 BELGIUM PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 202 BELGIUM SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 203 BELGIUM AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 204 BELGIUM HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 205 BELGIUM OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 206 BELGIUM SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 207 BELGIUM SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 208 BELGIUM SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 209 BELGIUM SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 210 REST OF EUROPE SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 1 EUROPE SELF-INJECTION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
TABLE 2 EUROPE SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 3 EUROPE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 4 EUROPE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 5 EUROPE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY,2015 – 2024 (USD MILLION)
TABLE 6 EUROPE AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 7 EUROPE AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 8 EUROPE AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 9 EUROPE AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 10 EUROPE PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 11 EUROPE PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 12 EUROPE PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 13 EUROPE SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 14 EUROPE AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 15 EUROPE HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 16 EUROPE OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 17 EUROPE SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 18 EUROPE SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 19 EUROPE SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 20 EUROPE SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 21 GERMANY SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 22 GERMANY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT,2015 – 2024 (USD MILLION)
TABLE 23 GERMANY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 24 GERMANY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 25 GERMANY AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 26 GERMANY AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 27 GERMANY AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 28 GERMANY AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 29 GERMANY PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 30 GERMANY PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 31 GERMANY PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 32 GERMANY SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 33 GERMANY AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 34 GERMANY HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 35 GERMANY OTHERS SELF-INJECTION MARKET, BYAPPLICATION, 2015 – 2024 (USD MILLION)
TABLE 36 GERMANY SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 37 GERMANY SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 38 GERMANY SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 39 GERMANY SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 40 FRANCE SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 41 FRANCE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 42 FRANCE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 43 FRANCE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 44 FRANCE AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 45 FRANCE A;UTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 46 FRANCE AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 47 FRANCE AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 48 FRANCE PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 49 FRANCE PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 50 FRANCE PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 51 FRANCE SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 52 FRANCE AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 53 FRANCE HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 54 FRANCE OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 55 FRANCE SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 56 FRANCE SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 57 FRANCE SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 58 FRANCE SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 59 UK SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 60 UK NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 61 UK NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 62 UK NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 63 UK AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 64 UK AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 65 UK AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 66 UK AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 67 UK PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 68 UK PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 69 UK PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 70 UK SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 71 UK AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 72 UK HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 73 UK OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 74 UK SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 75 UK SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 76 UK SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 77 UK SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 78 SWITZERLAND SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 79 SWITZERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 80 SWITZERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 81 SWITZERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY,2015 – 2024 (USD MILLION)
TABLE 82 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 83 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 84 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 85 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 86 SWITZERLAND PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 87 SWITZERLAND PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 88 SWITZERLAND PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 89 SWITZERLAND SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 90 SWITZERLAND AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 91 SWITZERLAND HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 92 SWITZERLAND OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 93 SWITZERLAND SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 94 SWITZERLAND SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 95 SWITZERLAND SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 96 SWITZERLAND SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL
2015– 2024 (USD MILLION)
TABLE 97 SPAIN SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 98 SPAIN NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 99 SPAIN NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 100 SPAIN NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 101 SPAIN AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 102 SPAIN AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 103 SPAIN AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 104 SPAIN AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 105 SPAIN PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 106 SPAIN PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 107 SPAIN PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 108 SPAIN SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 109 SPAIN AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 110 SPAIN HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 111 SPAIN OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 112 SPAIN SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 113 SPAIN SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 114 SPAIN SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 115 SPAIN SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 116 ITALY SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 117 ITALY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 118 ITALY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 119 ITALY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 120 ITALY AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 121 ITALY AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 122 ITALY AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 123 ITALY AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 124 ITALY PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 125 ITALY PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 126 ITALY PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 127 ITALY SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 128 ITALY AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 129 ITALY HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 130 ITALY OTHER SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 131 ITALY SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 132 ITALY SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 133 ITALY SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 134 ITALY SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 135 NETHERLANDS SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 136 NETHERLANDS NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 137 NETHERLANDS NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 138 NETHERLANDS NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 139 NETHERLANDS AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 140 NETHERLANDS AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 141 NETHERLANDS AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 142 NETHERLANDS AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 143 NETHERLANDS PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 144 NETHERLANDS PEN INJECTORS DEVICE MARKET, BY DESIGN 2015 – 2024 (USD MILLION)
TABLE 145 NETHERLANDS PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 146 NETHERLANDSSELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 147 NETHERLANDS AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 148 NETHERLANDS HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 149 NETHERLANDS OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 150 NETHERLANDSSELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 151 NETHERLANDSSELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 152 NETHERLANDSSELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 153 NETHERLANDS SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 154 RUSSIA SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 155 RUSSIA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 156 RUSSIA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 157 RUSSIA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 158 RUSSIA AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 158 RUSSIA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 159 RUSSIA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 160 RUSSIA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 161 RUSSIA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 162 RUSSIA PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 163 RUSSIA PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 164 RUSSIA SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 165 RUSSIA AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 166 RUSSIA HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 167 RUSSIA OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 168 RUSSIA SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 169 RUSSIA SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 170 RUSSIA SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 171 RUSSIA SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION
TABLE 172 TURKEY SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 173 TURKEY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 174 TURKEY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 175 TURKEY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 176 TURKEY AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 177 TURKEY AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 178 TURKEY AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 179 TURKEY AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 180 TURKEY PEN INJECTORS DEVICE MARKET, BY PRODUCT 2015 – 2024 (USD MILLION)
TABLE 181 TURKEY PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 182 TURKEY PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 183 TURKEY SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 184 TURKEY AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 185 TURKEY HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 186 TURKEY OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 187 TURKEY SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 188 TURKEY SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 189 TURKEY SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 190 TURKEY SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 191 BELGIUM SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 192 BELGIUM NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 193 BELGIUM NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 194 BELGIUM NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 195 BELGIUM AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 196 BELGIUM AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 197 BELGIUM AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 198 BELGIUM AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 199 BELGIUM PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 200 BELGIUM PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 201 BELGIUM PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 202 BELGIUM SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 203 BELGIUM AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 204 BELGIUM HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 205 BELGIUM OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 206 BELGIUM SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 207 BELGIUM SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 208 BELGIUM SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 209 BELGIUM SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 210 REST OF EUROPE SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
